A recent study identified that downregulation of SNHG20 in HL-1 cardiomyocytes improved Ang II-induced cardiac fibrosis and hypertrophy, indicating a potential compensatory mechanism in our model (Li et al., 2021). The gene discussed is AGT; the disease is fibrosis.